FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer PR Newswire
Онкология
🎗️Лента новостей
Онкология
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer Yahoo Finance Singapore
Онкология
Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1
Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1 Oncodaily
Онкология
Причины необычной заболеваемости раком будут искать в провинции Канады
Причины необычной заболеваемости раком будут искать в провинции Канады vancouverok.com
Онкология
25 years after 9/11, lessons emerge for long-term care
Twenty-five years after the Sept. 11 terrorist attacks, long-term follow-up of people exposed to the disaster offers important lessons for managing chronic disease in disaster-exposed populations, according to a review published in JAMA. The review is based on data from the World Trade Center (WTC) Health Program…
🎗️
Онкология
Why Clinical Trial Deserts Are Harming Cancer Patients
Why Clinical Trial Deserts Are Harming Cancer Patients Cure Today
Онкология
Why Novel Cancer Vaccine Tested at UCSF Marks New Treatment Era
Why Novel Cancer Vaccine Tested at UCSF Marks New Treatment Era Cancer Health
Онкология
Combination therapy may improve immune response against advanced prostate cancer
Combining the targeted therapy olaparib with an additional immunotherapy may improve immune response in a subgroup of patients with metastatic castration-resistant prostate cancer who responded poorly to initial treatment, according to a Northwestern Medicine study published in The Journal of Clinical Investigation.
Онкология
Рыбак поймал редчайшую рыбу: ее особенности могут помочь в изучении рака
Рыбак поймал редчайшую рыбу: ее особенности могут помочь в изучении рака Общественная служба новостей
Онкология
Dana-Farber Launches Solavia Decision Suite to Bring Cancer Treatment Expertise Into Clinical Workflow
Dana-Farber Launches Solavia Decision Suite to Bring Cancer Treatment Expertise Into Clinical Workflow Oncodaily
Онкология
Ancient viral remnants in our genome may help predict response to chemotherapy
In a new study, researchers from King's College London trained AI models on multiple types of clinical and biological data to determine whether they could predict which patients with acute myeloid leukemia (AML) would respond to chemotherapy. They found that behavior related to ancient viral sequences in the genome…
Онкология
First-in-human study at UCI Health attacks pancreatic cancer with laser light | Newswise
First-in-human study at UCI Health attacks pancreatic cancer with laser light | Newswise Newswise
🎗️
Онкология
Four Approvals Reflect Growth in Hormone-Sensitive Prostate Cancer Treatment
Four Approvals Reflect Growth in Hormone-Sensitive Prostate Cancer Treatment Targeted Oncology
Онкология
Cancer centers continue to face persistent drug shortages
U.S. cancer centers continue to experience persistent shortages of medications that are foundational components of oncology care, according to survey results. All cancer centers that participated in a late-summer survey administered by National Comprehensive Cancer Network reported current shortages of at least one…
Онкология
Psilocybin Prevents Chemotherapy-Related Nerve Injury in Mice
Psilocybin Prevents Chemotherapy-Related Nerve Injury in Mice Cancer Health